GL1X · GenesisL1 explorer

UniProt O00482

Nuclear receptor subfamily 5 group A member 2 (O00482)

Nuclear receptor subfamily 5 group A member 2 (UniProt O00482): 45 experimental structures on GenesisL1, 12 ligands bound, 22 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
O00482
Protein
Nuclear receptor subfamily 5 group A member 2
Experimental structures
45
Predicted models
0
Ligands
12
Pockets
22 · 5 records with a druggable one

Structures

45 records of O00482 in the MolNFT archive: 45 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1YOKcrystal structure of human LRH-1 bound with TIF-2 peptide and phosphatidylglycerolx-ray diffractionA——
1YOKCrystal structure of human lrh-1 bound with tif-2 peptide and phosphatidylglycerolx-ray diffractionA——
1YUCHuman Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to Phospholipid and a Fragment of…x-ray diffractionA, B——
1YUCHuman nuclear receptor liver receptor homologue-1, lrh-1, bound to phospholipid and a fragment of…x-ray diffractionA, B——
1ZDUThe Crystal Structure of Human Liver Receptor Homologue-1x-ray diffractionA——
1ZDUThe crystal structure of human liver receptor homologue-1x-ray diffractionA——
2A66Human Liver Receptor Homologue DNA-Binding Domain (hLRH-1 DBD) in Complex with dsDNA from the…x-ray diffractionA——
2A66Human liver receptor homologue DNA-binding domain (hlrh-1 dbd) in complex with dsdna from the…x-ray diffractionA——
3TX7Crystal structure of LRH-1/beta-catenin complexx-ray diffractionB——
3TX7Crystal structure of lrh-1/BETA-catenin complexx-ray diffractionB——
4DORHuman Nuclear Receptor Liver Receptor Homologue-1, LRH-1, in its apo State Bound to a Fragment of…x-ray diffractionA, B——
4DORHuman nuclear receptor liver receptor homologue-1, lrh-1, in its apo state bound to a fragment of…x-ray diffractionA, B——
4DOSHuman Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to DLPC and a Fragment of TIF-2x-ray diffractionA——
4DOSHuman nuclear receptor liver receptor homologue-1, lrh-1, bound to dlpc and a fragment of tif-2x-ray diffractionA——
4IS8Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptorsx-ray diffractionA, B——
4IS8Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptorsx-ray diffractionA, B——
4ONIStructure of Human Orphan Receptor LRH1 bound to two bacterial phospholipidsx-ray diffractionA, B——
4ONIStructure of human orphan receptor LRH1 bound to two bacterial phospholipidsx-ray diffractionA, B——
4PLDHuman Nuclear Receptor Liver Receptor Homologue-1, LRH-1, in its apo State Bound to a Fragment of…x-ray diffractionA——
4PLDHuman nuclear receptor liver receptor homologue-1, lrh-1, in its apo state bound to a fragment of…x-ray diffractionA——
4PLEHuman Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to an E. Coli Phospholipid and a…x-ray diffractionA, C, E, G——
4PLEHuman nuclear receptor liver receptor homologue-1, lrh-1, bound to an E. COLI phospholipid and a…x-ray diffractionA, C, E, G——
4RWVCrystal structure of PIP3 bound human nuclear receptor LRH-1 (Liver Receptor Homolog 1, NR5A2) in…x-ray diffractionA——
4RWVCrystal structure of PIP3 bound human nuclear receptor lrh-1 (liver receptor homolog 1, NR5A2) in…x-ray diffractionA——
5L0MhLRH-1 DNA Binding Domain - 12bp Oct4 promoter complexx-ray diffractionAZN2 (best 0.38)
5L0MHlrh-1 DNA binding domain - 12BP OCT4 promoter complexx-ray diffractionAZN—
5L11Human Liver Receptor Homologue-1 (LRH-1) Bound to RJW100 and a Fragment of TIF-2x-ray diffractionARJW—
5L11Human liver receptor homologue-1 (lrh-1) bound to RJW100 and a fragment of tif-2x-ray diffractionARJW—
5SYZHuman liver receptor homologue-1 (lrh-1) bound to a RJW100 stereoisomer and a fragment of tif-2x-ray diffractionA71W—
5UNJStructure of human liver receptor homolog 1 in complex with PGC1A and RJW100x-ray diffractionARJW—
6OQXHuman liver receptor homolog-1 bound to the agonist 5N and a fragment of the TIF2 coregulatorx-ray diffractionAN1V—
6OQYHuman LRH-1 bound to the agonist 6N and a fragment of the Tif2 coregulatorx-ray diffractionAN2J5 (best 0.85)
6OQYHuman lrh-1 bound to the agonist 6N and a fragment of the TIF2 coregulatorx-ray diffractionAN2J—
6OR1Human LRH-1 bound to the agonist 2N and a fragment of the Tif2 coregulatorx-ray diffractionAN274 (best 0.86)
6OR1Human lrh-1 bound to the agonist 2N and a fragment of the TIF2 coregulatorx-ray diffractionAN27—
6VC2Lrh-1 bound to ss-RJW100 and a fragment of the TIF2 coactivatorx-ray diffractionAQU7—
6VIFHuman lrh-1 ligand-binding domain bound to agonist cpd 15 and fragment of coregulator tif-2x-ray diffractionAQY4—
7JYDHuman Liver Receptor Homolog-1 in Complex with 10CA and a Fragment of Tif2x-ray diffractionAVQA4 (best 0.84)
7JYDHuman liver receptor homolog-1 in complex with 10CA and a fragment of TIF2x-ray diffractionAVQA—
7JYEHuman Liver Receptor Homolog-1 in Complex with 9ChoP and a Fragment of Tif2x-ray diffractionAVQY4 (best 0.84)
7JYEHuman liver receptor homolog-1 in complex with 9CHOP and a fragment of TIF2x-ray diffractionAVQY—
7TT8Human lrh-1 lbd bound to agonist 6N-10CA and fragment of TIF2 coactivatorx-ray diffractionAIUW—
8F8MLRH-1 bound to small molecule Tet and fragment of coactivator Tif2x-ray diffractionAXKE3 (best 0.84)
8PKICryo-EM structure of NR5A2-nucleosome complex SHL+5.5electron microscopyKZN—
O00482AlphaFold monomer V2.0 prediction for nuclear receptor subfamily 5 group a member 2 (O00482)———

Ligands

  • RJW · (1r,3ar,6ar)-5-hexyl-4-phenyl-3A-(1-phenylethenyl)-1,2, 3,3A,6,6A-hexahydropentalen-1-ol · in 3 records
  • ZN · Zinc ion · in 3 records
  • N27 · N-[(1S,3aR,6aR)-5-hexyl-4-phenyl-3a-(1-phenylethenyl)-1,2,3,3a,6,6a-hexahydropentalen-1-yl]acetamide · in 2 records
  • N2J · N-[(1S,3aR,6aR)-5-hexyl-4-phenyl-3a-(1-phenylethenyl)-1,2,3,3a,6,6a-hexahydropentalen-1-yl]sulfuric diamide · in 2 records
  • VQA · 10-[(3aR,6R,6aR)-6-hydroxy-3-phenyl-3a-(1-phenylethenyl)-1,3a,4,5,6,6a-hexahydropentalen-2-yl]decanoic acid · in 2 records
  • VQY · 9-[(3~{a}~{R},6~{R},6~{a}~{R})-6-oxidanyl-3-phenyl-3~{a}-(1-phenylethenyl)-4,5,6,6~{a}-tetrahydro-1~{H}-pentalen-2-yl]nonyl 2-(trimethyl-$l^{4}-azanyl)ethyl hydrogen phosphate · in 2 records
  • 71W · (1s,3ar,6ar)-5-hexyl-4-phenyl-3A-(1-phenylethenyl)-1,2, 3,3A,6,6A-hexahydropentalen-1-ol · in 1 record
  • IUW · 10-[(3aR,6S,6aR)-3-phenyl-3a-(1-phenylethenyl)-6-(sulfamoylamino)-1,3a,4,5,6,6a-hexahydropentalen-2-yl]decanoic acid (non-preferred name) · in 1 record
  • N1V · (8beta,11alpha,12alpha)-8-(1-phenylethenyl)-1,6:7,14-dicycloprosta-1,3,5,7(14)-tetraen-11-yl sulfamate · in 1 record
  • QU7 · (1s,3as,6as)-5-hexyl-4-phenyl-3A-(1-phenylethenyl)-1,2, 3,3A,6,6A-hexahydropentalen-1-ol · in 1 record
  • QY4 · N-[(8beta,11alpha,12alpha)-8-{[methyl(phenyl) amino]methyl}-1,6:7,14-dicycloprosta-1(6),2,4,7(14)-tetraen-11-yl]sulfuric diamide · in 1 record
  • XKE · (1~{R},3~{a}~{R},6~{a}~{R})-4-phenyl-3~{a}-(1-phenylethenyl)-5-[9-(1~{H}-1,2,3,4-tetrazol-5-yl)nonyl]-2,3,6,6~{a}-tetrahydro-1~{H}-pentalen-1-ol · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.